Filter
97
Filtered Results: 97
Text search:
cutaneous
leishmaniasis
(CL)
Featured
Recommendations
6
New Publications
8
Language
Document type
Studies & Reports
34
No document type
19
Videos
10
Guidelines
9
Resource Platforms
8
Fact sheets
5
Strategic & Response Plan
4
Manuals
3
Infographics
3
Training Material
2
Countries / Regions
Global
39
Latin America and the Carribbean
11
Ethiopia
11
India
5
Middle East and North Africa
4
Sudan
4
Nepal
3
Kenya
3
Asia
3
Bangladesh
3
Brazil
3
South Sudan
3
Africa
2
Greece
2
Somalia
2
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Senegal
1
Morocco
1
Jordan
1
Germany
1
Saudi Arabia
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Paraguay
1
North America
1
Tunisia
1
East and Southern Africa
1
Southern Africa
1
Lebanon
1
Uganda
1
Eastern Europe
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
22
Disease Prevention & Control
17
Statistics
8
Guidelines
7
Vector Control
4
Health System Strengthening
3
Studies & Reports
3
NTDs & Others
3
Policies
2
Parasitology
2
Pharmacy & Technologies
2
Paediatrics
1
Buruli Ulcer
1
Gender
1
Dermatology
1
Pediatrics
1
WASH
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Maternal Health
1
Food Security & Nutrition
1
Toolboxes
Studies & Reports
22
Leishmaniasis
17
Information & Education Material (IEC)
16
Vector control
8
Statistics & Facts
7
Overview, Studies & Reports
6
Clinical Aspects & Diagnostics
5
Capacity Building & Resources
4
NTDs General
4
General documents One Health
2
Studies & Reports
2
Clinical Aspects, Treatment & Prevention
1
WASH
1
Prevention Guidelines
1
Food and Nutrition
1
Community Health Workers CHW
1
Agriculture
1
Pharmacy
1
Essential Medicines
1
Traditional & Herbal Medicines
1
NTDs
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Studies & Reports
1
Other NTDs
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Yaws & other Endemic Treponematoses
1
General
1
Global Health Education
1
Website last accessed on 07.06.2023
Stopleishmania.org is an initiative of the VISAVET Health Surveillance Centre (UCM), the National Centre of Microbiology (ISCIII), the Animal Protection Centre (Madrid City Council) and the Directorate of Public Health (Regional Government of Madrid). This proj...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Website last accessed on 04.06.2023
Treatment options for Visceral Leishmaniasis in HIV-coinfected people include oral miltefosine; find additional information on diagnosis and ART treatment.
Website last accessed on 14.04.2023
Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
Website last accessed on 18.03.2023
WHO often receives requests from Member States and implementing partners to provide training in capacity‐building in endemic areas in order to better equip health personnel to diagnose, treat and control the disease.
Leishmaniasis is a spectrum of disease caused by the infection of protozoan parasite Leishmania mainly affecting the antigen presenting cell of the host. The disease is although considered as neglected tropical disease still it is not completely eradicated. Majority of the issues related to the ther...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions:
to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burde...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Aide-mémoire - Leishmaniose
Website last accessed on 22.05.2023
Youtube Video:
Maureen Richards Immunology & Microbiology - Leishmania
2nd edition
